Based on the substantial relationship between positive ITGAM expression and AML classification and clinical features, we further analyzed the pathway enrichment in the high versus low ITGAM expression group using TCGA-LAML expression profile data. This evidence concerns the gene ITGAM and acute myeloid leukemia.